Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After ⁹⁰Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity

Matthew M. Cousins, Theresa P. Devasia, Christopher M. Maurino, Justin Mikell, Matthew J. Schipper, Ravi K. Kaza, Theodore S. Lawrence, Kyle C. Cuneo, Yuni K. Dewaraja

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After ⁹⁰Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity

Fingerprint

Medicine & Life Sciences

Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After ⁹⁰Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity